ANG2

By Targets:	ERK (1) Small Interfering RNA (siRNA) (4) Tie (7) VEGFR (5)
By Research Areas:	Cancer (7) Cardiovascular Disease (4) Inflammation/Immunology (5) Metabolic Disease (1)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (2) siRNAs (4)

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P99116

Faricimab RG7716; RO-6867461	VEGFR	Cardiovascular Disease Metabolic Disease Inflammation/Immunology
Faricimab, an overall good safety and tolerability profile, is a bispecific antibody targeting Angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). Faricimab prevents retinal vascular leakage, cell death and inflammation in retinal ischemia/reperfusion (I/R) injury and sCNV mouse models. Faricimab demonstrates statistically superior visual acuity gains versus Ranibizumab (HY-P9951). Faricimab can be used for retinal diseases, such as age-related macular degeneration (w-AMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion (RVO) ^[2] .

HY-P99330

Vanucizumab Anti-Human VEGFA Recombinant Antibody; RO5520985	VEGFR Tie	Cancer
Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and **angiopoietin-2 (Ang-2)** from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects .

HY-P99036

Nesvacumab	Tie	Cardiovascular Disease Inflammation/Immunology Cancer
Nesvacumab is a fully human immunoglobulin G1 (IgG1) monoclonal antibody that specifically binds and inactivates the Tie2 receptor ligand *Angiopoietin-2* (Ang2) with high affinity, but shows no binding to Ang1. Nesvacumab can be used in vascular researches ^[2].

HY-P99510

Zansecimab LY-3127804	Tie	Inflammation/Immunology Cancer
Zansecimab (LY-3127804) is a monoclonal antibody against angiopoietin 2 (Ang‑2). Zansecimab can be used in research on angiogenesis, immunomodulation and anti-tumor activity ^[2] .

HY-P99546

Trebananib 2xCon4C; AMG 386	Tie	Cardiovascular Disease Cancer
Trebananib (2xCon4C) is an Fc fusion peptibody. Trebananib exerts its effects by blocking the binding of angiopoietin 1 (Ang1) and angiopoietin 2 (Ang2) to the *TIE2* receptor. Trebananib has anti-angiogenic and anti-tumor activities ^[2] .

HY-N2666

5α-Hydroxycostic acid	VEGFR	Cancer
5α-Hydroxycostic acid, a eudesmane-type sesquiterpene, is isolated from the herb Laggera alata. 5α-Hydroxycostic acid inhibits angiogenesis and suppresses breast cancer cell migration through regulating *VEGF/VEGFR2* and *Ang2/Tie2* pathways .

HY-P991415

ASKG-712 AM712	VEGFR Tie	Others
ASKG-712 (AM712) is a recombinant anti-VEGF humanized monoclonal antibody and *Ang-2* antagonist peptide fusion protein. ASKG-712 can be used in Wet age-related macular degeneration and Diabetic macular oedema research .

HY-P991663

AMG-780	Tie	Cancer
AMG-780 is a fully human IgG2 antibody that targets angiopoietin 1 (Ang1) (IC₅₀ = 4.5 nM) and angiopoietin 2 (Ang2) (IC₅₀ = 0.06 nM). AMG-780 inhibits tumor growth in the Colo205 xenograft mouse model by inhibiting both *Ang1* and *Ang2*. AMG-780 is indicated for the research of cancers such as colon cancer ^[2].

HY-P992323

BI-836880	VEGFR Tie ERK	Cardiovascular Disease Cancer
BI-836880 is a humanized bispecific nanobody and a selective inhibitor of VEGF and *ANG2, with a K_d* of 16 pM for hANG2, an EC₅₀ of 1.4 nM for VEGF₁₆₅, and an EC₅₀ of 2.3 nM for VEGF₁₂₁. BI-836880 blocks ERK phosphorylation downstream of VEGF-A as well as *TIE2* phosphorylation downstream of *ANG2. BI-836880 does not inhibit ANG*1-mediated TIE2 phosphorylation. BI-836880 exerts anti-angiogenic effects, reduces the number of immature endothelial vessels in tumor tissues, and inhibits tumor growth in preclinical models. BI-836880 can be used in the research of pancreatic cancer, non-small cell lung cancer, renal cell carcinoma, ovarian cancer, colon cancer, and Lewis lung cancer .

HY-RS16719

Angpt2 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Angpt2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Angpt2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Angpt2 Mouse Pre-designed siRNA Set A Angpt2 Mouse Pre-designed siRNA Set A

HY-RS00688

ANGPT2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ANGPT2 Human Pre-designed siRNA Set A contains three designed siRNAs for ANGPT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ANGPT2 Human Pre-designed siRNA Set A ANGPT2 Human Pre-designed siRNA Set A

HY-RS23155

Angpt2 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Angpt2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Angpt2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Angpt2 Rat Pre-designed siRNA Set A Angpt2 Rat Pre-designed siRNA Set A

HY-RS15696

VPS51 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
VPS51 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS51 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VPS51 Human Pre-designed siRNA Set A VPS51 Human Pre-designed siRNA Set A

Cat. No.	Product Name	Target	Research Area	Image

HY-P99116

Faricimab RG7716; RO-6867461	VEGFR	Cardiovascular Disease Metabolic Disease Inflammation/Immunology
Faricimab, an overall good safety and tolerability profile, is a bispecific antibody targeting Angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A). Faricimab prevents retinal vascular leakage, cell death and inflammation in retinal ischemia/reperfusion (I/R) injury and sCNV mouse models. Faricimab demonstrates statistically superior visual acuity gains versus Ranibizumab (HY-P9951). Faricimab can be used for retinal diseases, such as age-related macular degeneration (w-AMD), diabetic macular edema (DME) and macular edema following retinal vein occlusion (RVO) ^[2] .

HY-P99330

Vanucizumab Anti-Human VEGFA Recombinant Antibody; RO5520985	VEGFR Tie	Cancer
Vanucizumab is a first-in-class, bispecific IgG1-like monoclonal antibody that simultaneously blocks VEGF-A and **angiopoietin-2 (Ang-2)** from interacting with their receptors. Vanucizumab has antiangiogenic and anticancer effects .

HY-P99036

Nesvacumab	Tie	Cardiovascular Disease Inflammation/Immunology Cancer
Nesvacumab is a fully human immunoglobulin G1 (IgG1) monoclonal antibody that specifically binds and inactivates the Tie2 receptor ligand *Angiopoietin-2* (Ang2) with high affinity, but shows no binding to Ang1. Nesvacumab can be used in vascular researches ^[2].

HY-P99510

Zansecimab LY-3127804	Tie	Inflammation/Immunology Cancer
Zansecimab (LY-3127804) is a monoclonal antibody against angiopoietin 2 (Ang‑2). Zansecimab can be used in research on angiogenesis, immunomodulation and anti-tumor activity ^[2] .

HY-P99546

Trebananib 2xCon4C; AMG 386	Tie	Cardiovascular Disease Cancer
Trebananib (2xCon4C) is an Fc fusion peptibody. Trebananib exerts its effects by blocking the binding of angiopoietin 1 (Ang1) and angiopoietin 2 (Ang2) to the *TIE2* receptor. Trebananib has anti-angiogenic and anti-tumor activities ^[2] .

HY-P990625

MEDI-3617	Inhibitory Antibodies	Inflammation/Immunology
MEDI-3617 is a humanized antibody expressed in CHO cells, targeting *Ang2/ANGPT2/Angiopoietin2*. MEDI-3617 has a huIgG2 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for MEDI-3617 can refer to Human IgG2 kappa, Isotype Control (HY-P99002).

HY-P990334

Anti-ANGPT2 Antibody	Inhibitory Antibodies	Inflammation/Immunology
Anti-ANGPT2 Antibody is a CHO-expressed human antibody that targets *Ang2/ANGPT2/Angiopoietin2. Anti-ANGPT2 Antibody has a huIgG1 type heavy chain and a huκ type light chain, with a predicted molecular weight (MW) of 150 kDa. The isotype control for Anti*-ANGPT2 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

HY-P991415

ASKG-712 AM712	VEGFR Tie	Others
ASKG-712 (AM712) is a recombinant anti-VEGF humanized monoclonal antibody and *Ang-2* antagonist peptide fusion protein. ASKG-712 can be used in Wet age-related macular degeneration and Diabetic macular oedema research .

HY-P991663

AMG-780	Tie	Cancer
AMG-780 is a fully human IgG2 antibody that targets angiopoietin 1 (Ang1) (IC₅₀ = 4.5 nM) and angiopoietin 2 (Ang2) (IC₅₀ = 0.06 nM). AMG-780 inhibits tumor growth in the Colo205 xenograft mouse model by inhibiting both *Ang1* and *Ang2*. AMG-780 is indicated for the research of cancers such as colon cancer ^[2].

HY-P992323

BI-836880	VEGFR Tie ERK	Cardiovascular Disease Cancer
BI-836880 is a humanized bispecific nanobody and a selective inhibitor of VEGF and *ANG2, with a K_d* of 16 pM for hANG2, an EC₅₀ of 1.4 nM for VEGF₁₆₅, and an EC₅₀ of 2.3 nM for VEGF₁₂₁. BI-836880 blocks ERK phosphorylation downstream of VEGF-A as well as *TIE2* phosphorylation downstream of *ANG2. BI-836880 does not inhibit ANG*1-mediated TIE2 phosphorylation. BI-836880 exerts anti-angiogenic effects, reduces the number of immature endothelial vessels in tumor tissues, and inhibits tumor growth in preclinical models. BI-836880 can be used in the research of pancreatic cancer, non-small cell lung cancer, renal cell carcinoma, ovarian cancer, colon cancer, and Lewis lung cancer .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N2666

5α-Hydroxycostic acid	Other Terpenoids Classification of Application Fields Terpenoids Erythrina burttii Baker f. Plants Compositae Disease Research Fields Cancer Source Classification	VEGFR
5α-Hydroxycostic acid, a eudesmane-type sesquiterpene, is isolated from the herb Laggera alata. 5α-Hydroxycostic acid inhibits angiogenesis and suppresses breast cancer cell migration through regulating *VEGF/VEGFR2* and *Ang2/Tie2* pathways .

Recombinant Proteins Recommended:

ANG-2

Species:	Human (9) Rhesus Macaque (4) Mouse (3) Cynomolgus (4) Dog (2)
Tag:	His (14) Avi (4) Fc (4)
Source:	HEK293 (16) CHO (2)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P700396

	ANGPT2/Angiopoietin-2 Protein, Dog (HEK293, His) ANGiopoietin 2; ANGiopoietin-2; ANG2; ANG-2; Tie2-ligand; ANGiopoietin-2B; ANGiopoietin-2a; ANG2; AGPT2;	Dog	HEK293
	ANGPT2/Angiopoietin-2 (dog) complexly regulates angiogenesis by binding to TEK/TIE2, competitively affecting ANGPT1 signaling. It independently induces TEK/TIE2 phosphorylation and, in the absence of VEGF, may cause endothelial cell apoptosis, thereby promoting vascular regression. ANGPT2/Angiopoietin-2 Protein, Dog (HEK293, His) is the recombinant dog-derived ANGPT2/Angiopoietin-2, Dog, expressed by HEK293 , with C-6*His labeled tag.

HY-P7510

	Angiopoietin-2 Protein, Human (HEK293, His) 2 Publications Verification rHuANGiopoietin-2, His; ANGPT2; ANG2; ANGiopoietin-2	Human	HEK293
	Angiopoietin-2 Protein, Human (HEK293, His) is a circulating antagonistic ligand of the endothelial-specific Tie2 receptor and has been identified as an important gatekeeper of endothelial activation.

HY-P7844

	Angiopoietin-2 Protein, Mouse (HEK293, Fc) rMuANGiopoietin-2/ANG2, Fc ; AGPT2; ANG2; ANG-2; ANGiopoietin 2; ANGiopoietin-2; ANGiopoietin-2a; ANGiopoietin-2B; ANGiopoitin 2; ANGPT2; Tie2-ligand	Mouse	HEK293
	Angiopoietin 2 protein (ANGPT2) binds to TEK/TIE2, competes with ANGPT1, and modulates its signaling. Even in the absence of ANGPT1, ANGPT2 induces TEK/TIE2 phosphorylation. Angiopoietin-2 Protein, Mouse (HEK293, Fc) is the recombinant mouse-derived Angiopoietin-2 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P78381

	Angiopoietin-2 Protein, Human (HEK293, His-Avi) AGPT2; ANG2; ANG-2; ANGiopoietin 2; ANGiopoietin-2; ANGiopoietin-2a; ANGiopoietin-2B; ANGiopoitin 2; ANGPT2; Tie2-ligand	Human	HEK293
	Angiopoietin-2 (ANGPT2) protein competes with ANGPT1 for TEK/TIE2 binding, modulates ANGPT1 signaling and induces TEK/TIE2 phosphorylation even in the absence of ANGPT1. In the absence of angiogenic stimulation, ANGPT2 disrupts cell-matrix contacts, potentially triggering endothelial cell apoptosis and vessel regression. Angiopoietin-2 Protein, Human (HEK293, His-Avi) is the recombinant human-derived Angiopoietin-2 protein, expressed by HEK293 , with N-His, N-Avi labeled tag.

HY-P703964

	FITC-Labeled Angiopoietin-2 Protein, Human (HEK293, His) AGPT2; ANG2; ANG-2; ANGiopoietin 2; ANGiopoietin-2; ANGiopoietin-2a; ANGiopoietin-2B; ANGiopoitin 2; ANGPT2; Tie2-ligand	Human	HEK293
	Angiopoietin-2 (ANGPT2) protein competes with ANGPT1 for TEK/TIE2 binding, modulates ANGPT1 signaling and induces TEK/TIE2 phosphorylation even in the absence of ANGPT1. In the absence of angiogenic stimulation, ANGPT2 disrupts cell-matrix contacts, potentially triggering endothelial cell apoptosis and vessel regression. FITC-Labeled Angiopoietin-2 Protein, Human (HEK293, His) is the recombinant human-derived FITC-Labeled Angiopoietin-2 protein, expressed by HEK293, with N-His labeled tag.

HY-P78061

	Angiopoietin-2 Protein, Human (Biotinylated, HEK293, His-Avi) AGPT2; ANG2; ANG-2; ANGiopoietin 2; ANGiopoietin-2; ANGiopoietin-2a; ANGiopoietin-2B; ANGiopoitin 2; ANGPT2; Tie2-ligand	Human	HEK293
	Angiopoietin-2 (ANGPT2) protein competes with ANGPT1 for TEK/TIE2 binding, modulates ANGPT1 signaling and induces TEK/TIE2 phosphorylation even in the absence of ANGPT1. In the absence of angiogenic stimulation, ANGPT2 disrupts cell-matrix contacts, potentially triggering endothelial cell apoptosis and vessel regression. Angiopoietin-2 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived Angiopoietin-2 protein, expressed by HEK293 , with N-His, N-Avi labeled tag.

HY-P78651

	FITC-Labeled Angiopoietin-2 Protein, Human (HEK293, His-Avi) ANGPT2; AGPT2; ANG2; ANGiopoietin-2	Human	HEK293
	Angiopoietin-2 (ANGPT2) protein competes with ANGPT1 for TEK/TIE2 binding, modulates ANGPT1 signaling and induces TEK/TIE2 phosphorylation even in the absence of ANGPT1. In the absence of angiogenic stimulation, ANGPT2 disrupts cell-matrix contacts, potentially triggering endothelial cell apoptosis and vessel regression. FITC-Labeled Angiopoietin-2 Protein, Human (HEK293, His-Avi) is the recombinant human-derived FITC-Labeled Angiopoietin-2 protein, expressed by HEK293 , with N-His-Avi labeled tag.

HY-P70123

	Angiopoietin-2 Protein, Cynomolgus/Rhesus Macaque (HEK293, hFc) rRhANG2, Fc; AGPT2; ANG2; ANG-2; ANGiopoietin 2; ANGiopoietin-2; ANGiopoietin-2a; ANGiopoietin-2B; ANGiopoitin 2; ANGPT2; Tie2-ligand	Rhesus Macaque;Cynomolgus	HEK293
	ANGPT2 is a secreted factor on the angiopoietin/Tie (tyrosine kinase with Ig and EGF homology domains) signaling pathway and is involved in tumor angiogenesis. In the presence of ANGPT1, ANGPT2 antagonizes ANGPT1-mediated Tie2 phosphorylation, leading to vessel sprouting or degeneration depending on the level of VEGF-A. Overexpression or inhibition of ANGPT2 increases or decreases angiogenic capacity, respectively. Angiopoietin-2 Protein, Cynomolgus/Rhesus Macaque (HEK293, hFc) is the recombinant Rhesus Macaque-derived Angiopoietin-2 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P704975

	Angiopoietin-2 Protein, Human (Biotinylated, 478a.a, HEK293, His-Avi) AGPT2; ANG2; ANG-2; ANGiopoietin 2; ANGiopoietin-2; ANGiopoietin-2a; ANGiopoietin-2B; ANGiopoitin 2; ANGPT2; Tie2-ligand	Human	HEK293

HY-P704354

	Angiopoietin-2 Protein, Mouse (CHO, His) ANGiopoietin-2; ANG-2; ANGPT2	Mouse	CHO
	Angiopoietin 2 protein (ANGPT2) binds to TEK/TIE2, competes with ANGPT1, and modulates its signaling. Even in the absence of ANGPT1, ANGPT2 induces TEK/TIE2 phosphorylation. Angiopoietin-2 Protein, Mouse (CHO, His) is the recombinant mouse-derived Angiopoietin-2 protein, expressed by CHO, with C-His labeled tag.

HY-P72828

	Angiopoietin-2 Protein, Human (CHO, His) ANGiopoietin-2; ANG-2; ANGPT2	Human	CHO
	Angiopoietin-2 (ANGPT2) protein competes with ANGPT1 for TEK/TIE2 binding, modulates ANGPT1 signaling and induces TEK/TIE2 phosphorylation even in the absence of ANGPT1. In the absence of angiogenic stimulation, ANGPT2 disrupts cell-matrix contacts, potentially triggering endothelial cell apoptosis and vessel regression. Angiopoietin-2 Protein, Human (CHO, His) is the recombinant human-derived Angiopoietin-2 protein, expressed by CHO , with C-6*His labeled tag.

HY-P72827

	Angiopoietin-2 Protein, Human (HEK293, Fc) ANGiopoietin-2; ANG-2; ANGPT2	Human	HEK293
	Angiopoietin-2 (ANGPT2) protein competes with ANGPT1 for TEK/TIE2 binding, modulates ANGPT1 signaling and induces TEK/TIE2 phosphorylation even in the absence of ANGPT1. In the absence of angiogenic stimulation, ANGPT2 disrupts cell-matrix contacts, potentially triggering endothelial cell apoptosis and vessel regression. Angiopoietin-2 Protein, Human (HEK293, Fc) is the recombinant human-derived Angiopoietin-2 protein, expressed by HEK293 , with C-hFc labeled tag.

HY-P72830

	Angiopoietin-2 Protein, Mouse (HEK293, His) ANGiopoietin-2; ANG-2; ANGPT2	Mouse	HEK293
	Angiopoietin 2 protein (ANGPT2) binds to TEK/TIE2, competes with ANGPT1, and modulates its signaling. Even in the absence of ANGPT1, ANGPT2 induces TEK/TIE2 phosphorylation. Angiopoietin-2 Protein, Mouse (HEK293, His) is the recombinant mouse-derived Angiopoietin-2 protein, expressed by HEK293 , with N-His labeled tag.

HY-P76149

	Angiopoietin-2 Protein, Cynomolgus/Rhesus Macaque (HEK293, His) ANGiopoietin-2; ANG-2; ANGPT2	Rhesus Macaque;Cynomolgus	HEK293
	Angiopoietin-2 (Ang2) is a growth factor that belongs to the angiopoietin/Tie (tyrosine kinase with Ig and EGF homology domains) signaling pathway, which is one of the main pathways involved in angiogenesis. Ang2 is a 496 amino acid long protein with a secretory signal peptide, an NH2-terminal coiled-coil domain, and a COOH-terminal fibrinogen-like domain. Ang2 mainly inhibits Ang1-induced Tie2 phosphorylation. Ang2 is critical for endothelial cell physiology and plays a central role in vascular-related diseases by regulating endothelial permeability and angiogenic functions. Angiopoietin-2 Protein, Cynomolgus/Rhesus Macaque (HEK293, His) is the recombinant Rhesus Macaque-derived Angiopoietin-2 protein, expressed by HEK293 , with C-His labeled tag.

HY-P72829

	Angiopoietin-2 Protein, Human (478a.a, HEK293, His) 1 Publications Verification ANGiopoietin-2; ANG-2; ANGPT2	Human	HEK293
	Angiopoietin-2 (ANGPT2) protein competes with ANGPT1 for TEK/TIE2 binding, modulates ANGPT1 signaling and induces TEK/TIE2 phosphorylation even in the absence of ANGPT1. In the absence of angiogenic stimulation, ANGPT2 disrupts cell-matrix contacts, potentially triggering endothelial cell apoptosis and vessel regression. Angiopoietin-2 Protein, Human (478a.a, HEK293, His) is the recombinant human-derived Angiopoietin-2 protein, expressed by HEK293 , with C-His labeled tag.

HY-P75509

	ANGPT2/Angiopoietin-2 Protein, Dog (222a.a, HEK293, His) ANGiopoietin-2; ANG-2; ANGPT2	Dog	HEK293
	ANGPT2/Angiopoietin-2 (dog) complexly regulates angiogenesis by binding to TEK/TIE2, competitively affecting ANGPT1 signaling. It independently induces TEK/TIE2 phosphorylation and, in the absence of VEGF, may cause endothelial cell apoptosis, thereby promoting vascular regression. ANGPT2/Angiopoietin-2 Protein, Dog (222a.a, HEK293, His) is the recombinant dog-derived Angiopoietin-2 protein, expressed by HEK293 , with N-His labeled tag.

HY-P76148

	Angiopoietin-2 Protein, Cynomolgus/Rhesus Macaque (222a.a, HEK293, His) ANGiopoietin-2; ANG-2; ANGPT2	Rhesus Macaque;Cynomolgus	HEK293
	Angiopoietin-2 (Ang2) is a growth factor that belongs to the angiopoietin/Tie (tyrosine kinase with Ig and EGF homology domains) signaling pathway, which is one of the main pathways involved in angiogenesis. Ang2 is a 496 amino acid long protein with a secretory signal peptide, an NH2-terminal coiled-coil domain, and a COOH-terminal fibrinogen-like domain. Ang2 mainly inhibits Ang1-induced Tie2 phosphorylation. Ang2 is critical for endothelial cell physiology and plays a central role in vascular-related diseases by regulating endothelial permeability and angiogenic functions. Angiopoietin-2 Protein, Cynomolgus/Rhesus Macaque (222a.a, HEK293, His) is the recombinant Rhesus Macaque-derived Angiopoietin-2 protein, expressed by HEK293 , with N-His labeled tag.

HY-P76147

	Angiopoietin-2 Protein, Cynomolgus/Rhesus Macaque (222a.a, HEK293, Fc) ANGiopoietin-2; ANG-2; ANGPT2	Rhesus Macaque;Cynomolgus	HEK293
	Angiopoietin-2 (Ang2) is a growth factor that belongs to the angiopoietin/Tie (tyrosine kinase with Ig and EGF homology domains) signaling pathway, which is one of the main pathways involved in angiogenesis. Ang2 is a 496 amino acid long protein with a secretory signal peptide, an NH2-terminal coiled-coil domain, and a COOH-terminal fibrinogen-like domain. Ang2 mainly inhibits Ang1-induced Tie2 phosphorylation. Ang2 is critical for endothelial cell physiology and plays a central role in vascular-related diseases by regulating endothelial permeability and angiogenic functions. Angiopoietin-2 Protein, Cynomolgus/Rhesus Macaque (222a.a, HEK293, Fc) is the recombinant Rhesus Macaque-derived Angiopoietin-2 protein, expressed by HEK293 , with N-hFc labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P81853

	Angiopoietin 2 Antibody (YA1598) ANGiopoietin-2 (ANG-2)	WB, IHC-P	Human, Mouse, Rat
	Angiopoietin 2 Antibody (YA1598) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Angiopoietin 2.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name		Classification

HY-RS16719

Angpt2 Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Angpt2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Angpt2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS00688

ANGPT2 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
ANGPT2 Human Pre-designed siRNA Set A contains three designed siRNAs for ANGPT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS23155

Angpt2 Rat Pre-designed siRNA Set A		siRNAs Rat Pre-designed siRNA Sets
Angpt2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Angpt2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HY-RS15696

VPS51 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
VPS51 Human Pre-designed siRNA Set A contains three designed siRNAs for VPS51 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Antibodies

Oligonucleotides